Zobrazeno 1 - 6
of 6
pro vyhledávání: '"S Bastien Salas"'
Autor:
Margaux Vieille, Lionel Dany, Pierre Le Coz, Sophie Avon, Charlotte Keraval, S?bastien Salas, C?cile Bernard
Publikováno v:
Palliative Medicine Reports, Vol 2, Iss 1, Pp 160-167 (2021)
Background: Palliative care teams face complex medical situations on a daily basis. These situations require joint reflection and decision making to propose appropriate patient care. Sometimes, sedation is one of the options to be considered. In addi
Externí odkaz:
https://doaj.org/article/ae9a54c2811849e1b3723371130fa126
Autor:
Nicolas Penel, Guillaume Vogin, Emmanuelle Bompas, Thibaud Valentin, Julien Mancini, Loic Chaigneau, S Bastien Salas, Jean-Yves Blay, Olivier Collard, Edouard Auclin, Maud Toulmonde, Florence Duffaud, Axel Le Cesne, Isabelle Ray-Coquard, Maria Rios, Antoine Adenis, Marc Pracht, Antoine Italiano, Bruno Landi, François Bertucci
Publikováno v:
Journal of Clinical Oncology. 35:11041-11041
11041 Background: A subset of metastatic GIST exhibit very long-term survival after imatinib (IM) introduction. The aim of this study was to analyse the clinico-biological characteristics of GIST pts alive > 10 years (yrs) after diagnosis (dx) of met
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e0696f8ae92d48969f4cc2da49d75c2f
https://doi.org/10.1200/jco.2017.35.15_suppl.11041
https://doi.org/10.1200/jco.2017.35.15_suppl.11041
Autor:
Thibaud Valentin, Sophie Piperno Neumann, Agnès Ducoulombier, Jean-Yves Blay, Nelly Firmin, C. Llacer, Clémentine Owen, Nicolas Isambert, Esma Saada-Bouzid, François Bertucci, Christophe Sajous, Sébastien Carrère, Jacques-Olivier Bay, Emmanuelle Bompas, Didier Cupissol, Mathias Neron, Simon Thezenas, S Bastien Salas, Camille Chakiba, Aurélie Maran-Gonzalez
Publikováno v:
Journal of Clinical Oncology. 35:11055-11055
11055 Background: The optimal management of malignant phyllod tumors (MPT) is poorly documented. Objective:To study the characteristics and outcome of MPT patients (pts). Methods: Retrospective study from the nation-wide French sarcoma network (NetSa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e22074e88d3c3d680b1bd3939bb1e521
https://doi.org/10.1200/jco.2017.35.15_suppl.11055
https://doi.org/10.1200/jco.2017.35.15_suppl.11055
Autor:
C. Lefeuvre-Plesse, Veronique Girre, Nadine Houede, Carole Helissey, Alain Zannetti, Laurence Vanlemmens, Jean-Marc Descotes, Laetitia Stefani, Bénédicte Mastroianni, S Bastien Salas, Florence Joly Lobbedez, Nathalie Meneveau, Claire Garnier-Tixidre, Valérie Plence, Claude Boiron, Franck Bonnetain, Sophie Abadie-Lacourtoisie, Stéphane Oudard, Frank Priou, Ivan Krakowski
Publikováno v:
Journal of Clinical Oncology. 35:TPS10126-TPS10126
TPS10126 Background: Fatigue is a frequent side effect with oral targeted therapies (OTT). Physical activity has been reported to improve fatigue and quality of life (QoL). However, few studies focused on metastatic cancer patients and mainly among p
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2a9a44d8a2258ba07d0e0a155429475b
https://doi.org/10.1200/jco.2017.35.15_suppl.tps10126
https://doi.org/10.1200/jco.2017.35.15_suppl.tps10126
Autor:
Julien Thery, Jennifer Wallet, Jean-Yves Blay, Corinne Delcambre, Thomas Brodowicz, Christophe Perrin, Maud Toulmonde, Olivier Mir, Sophie Piperno-Neumann, Marie-Cécile Le Deley, Bernadette Lieg-Atzwanger, Antoine Italiano, Axel Le Cesne, Nuria Kotecki, Isabelle Ray-Coquard, Emmanuelle Bompas, S Bastien Salas, Nicolas Penel, François Bertucci, Christine Chevreau
Publikováno v:
Journal of Clinical Oncology. 35:11052-11052
11052 Background: Based on the placebo (PBO) controlled phase 2 trial (Mir, Lancet Oncol 2016), RE has shown to be an active drug in patients (pts) with leiomyosarcoma (LMS), synovial sarcoma (SS) and other non-adipocytic sarcoma (OTH), but not in li
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::37d6f4e86c51d11ebf73da8ebadced25
https://doi.org/10.1200/jco.2017.35.15_suppl.11052
https://doi.org/10.1200/jco.2017.35.15_suppl.11052
Autor:
L'Houcine Ouafik, Sylvie Bonvalot, Nicolas Macagno, Isabelle Nanni, T Bouhadiba, Florence Duffaud, Raquel Rouah, Nicolas Penel, S Bastien Salas, Corinne Bouvier, Frédéric Fina
Publikováno v:
Journal of Clinical Oncology. 35:11063-11063
11063 Background: Since desmoid tumors (DT) exhibit an unpredictable clinical course, with stabilization and/or spontaneous regression, an initial “wait-and-see” policy is the new standard of care to select best indications of active treatments i
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e38f15f81f80272616ca6adaa61e6cf8
https://doi.org/10.1200/jco.2017.35.15_suppl.11063
https://doi.org/10.1200/jco.2017.35.15_suppl.11063